Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Demographic Analysis of Cancer Research Priorities and Treatment Correlations.
Horgan D, Van den Bulcke M, Malapelle U, Normanno N, Capoluongo ED, Prelaj A, Rizzari C, Stathopoulou A, Singh J, Kozaric M, Dube F, Ottaviano M, Boccia S, Pravettoni G, Cattaneo I, Malats N, Buettner R, Lekadir K, de Lorenzo F, Alix-Panabieres C, Badreh S, Solary E, De Maria R, Hofman P. Horgan D, et al. Among authors: de lorenzo f. Curr Oncol. 2024 Mar 29;31(4):1839-1864. doi: 10.3390/curroncol31040139. Curr Oncol. 2024. PMID: 38668042 Free PMC article.
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission.
Casolino R, Johns AL, Courtot M, Lawlor RT, De Lorenzo F, Horgan D, Mateo J, Normanno N, Rubin M, Stein L, Subbiah V, Westphalen BC, Lawler M, Park K, Perdomo S, Yoshino T, Wu J, Biankin AV; Lancet Oncology Commission on Cancer Omics and Precision Oncology. Casolino R, et al. Among authors: de lorenzo f. Lancet Oncol. 2023 Feb;24(2):123-125. doi: 10.1016/S1470-2045(23)00007-4. Lancet Oncol. 2023. PMID: 36725142 Free article. No abstract available.
Towards a cancer mission in Horizon Europe: recommendations.
Berns A, Ringborg U, Celis JE, Heitor M, Aaronson NK, Abou-Zeid N, Adami HO, Apostolidis K, Baumann M, Bardelli A, Bernards R, Brandberg Y, Caldas C, Calvo F, Dive C, Eggert A, Eggermont A, Espina C, Falkenburg F, Foucaud J, Hanahan D, Helbig U, Jönsson B, Kalager M, Karjalainen S, Kásler M, Kearns P, Kärre K, Lacombe D, de Lorenzo F, Meunier F, Nettekoven G, Oberst S, Nagy P, Philip T, Price R, Schüz J, Solary E, Strang P, Tabernero J, Voest E. Berns A, et al. Among authors: de lorenzo f. Mol Oncol. 2020 Aug;14(8):1589-1615. doi: 10.1002/1878-0261.12763. Mol Oncol. 2020. PMID: 32749074 Free PMC article.
Cancer survivorship: an integral part of Europe's research agenda.
Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L, Faithfull S, Liu L, Meunier F, Ulrich C; European Academy of Cancer Sciences. Lagergren P, et al. Among authors: de lorenzo f. Mol Oncol. 2019 Mar;13(3):624-635. doi: 10.1002/1878-0261.12428. Epub 2019 Jan 8. Mol Oncol. 2019. PMID: 30552794 Free PMC article. Review.
Greater patient access to immuno-oncology therapies-what can policymakers do?
de Lorenzo F, Wait S, Karaca B, Britten CM, van den Bulcke M; European Expert Group on Immuno-Oncology. de Lorenzo F, et al. Ecancermedicalscience. 2015 Feb 25;9:ed48. doi: 10.3332/ecancer.2015.ed48. eCollection 2015. Ecancermedicalscience. 2015. PMID: 25729428 Free PMC article. No abstract available.
175 results